Basal T cell activation predicts yellow fever vaccine response independently of cytomegalovirus infection and sex-related immune variations

基础T细胞活化可独立于巨细胞病毒感染和性别相关的免疫变异预测黄热病疫苗的免疫应答。

阅读:8
作者:Antonio Santos-Peral ,Magdalena Zaucha ,Elena Nikolova ,Ekin Yaman ,Barbara Puzek ,Elena Winheim ,Sebastian Goresch ,Magdalena K Scheck ,Lisa Lehmann ,Frank Dahlstroem ,Hadi Karimzadeh ,Julia Thorn-Seshold ,Shenzhi Jia ,Fabian Luppa ,Michael Pritsch ,Julia Butt ,Camila Metz-Zumaran ,Giovanna Barba-Spaeth ,Stefan Endres ,Sarah Kim-Hellmuth ,Tim Waterboer ,Anne B Krug ,Simon Rothenfusser

Abstract

The live-attenuated yellow fever 17D (YF17D) vaccine is a model of acute viral infection that induces long-lasting protective immunity. Among immunocompetent adults, responses to YF17D vary significantly. To understand the sources of this variability, we investigate the influence of sex, age, human leukocyte antigen (HLA) type, and 20 prior infections on basal immune parameters and the cellular and antibody response to YF17D in 250 healthy young individuals. Multivariate regression found that sex and cytomegalovirus (CMV) infection significantly contribute to baseline immune variation but do not affect vaccine responses except for reduced YF17D-specific CD8+ frequencies in CMV-infected males. However, the abundance at baseline of non-specific cytokine-expressing T helper cells in circulation is associated with stronger vaccine responses, a state that smoking favors. Additionally, an elevated baseline level of interferon-stimulated CXCL10 is linked to poorer vaccination outcomes. Altogether, YF17D reactivity is conditioned by the baseline immune status independent of sex and CMV-related variations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。